Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:Japan
|
| gptkbp:division |
gptkb:Meiji_Holdings
|
| gptkbp:formerName |
Meiji Seika Kaisha
|
| gptkbp:founded |
1916
|
| gptkbp:headquartersLocation |
gptkb:Tokyo
|
| https://www.w3.org/2000/01/rdf-schema#label |
Meiji Seika Pharma
|
| gptkbp:industry |
healthcare
pharmaceuticals |
| gptkbp:languageOfName |
Japanese
|
| gptkbp:notableProduct |
gptkb:Avelox
psychiatric medications Avelox (moxifloxacin) antibiotic products |
| gptkbp:parentCompany |
gptkb:Meiji_Holdings
|
| gptkbp:product |
antibiotics
generic drugs vaccines psychiatric drugs |
| gptkbp:stockExchange |
gptkb:Tokyo_Stock_Exchange
|
| gptkbp:website |
https://www.meiji-seika-pharma.co.jp/
|
| gptkbp:bfsParent |
gptkb:Tebipenem_HBr
|
| gptkbp:bfsLayer |
8
|